JPRN-UMIN000036448
Completed
未知
A confirmation study of the influence for blood vessel by consumption of test food - A confirmation study of the influence for blood vessel by consumption of test food
CPCC Company Limited0 sites24 target enrollmentApril 10, 2020
ConditionsHealthy adults
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Healthy adults
- Sponsor
- CPCC Company Limited
- Enrollment
- 24
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Subjects who are given continuous treatment by taking medicines. 2\)Subjects who have previous and/or current medical history of serious disease (e.g.,digestive organ,circulatory organ,respiratory organ and urinary organ etc.). 3\)Subjects who excessive alcohol intake. 4\)Subjects who have extremely irregular dining habits,and subjects who have midnight work or irregular shift work. 5\)Subjects who have previous medical history of drug and/or food allergy. 6\)Subjects who regularly having medicines, quasi\-drugs,food for specified health uses,foods with function claim,health food and/or supplements. 7\)Subjects who participated within one month prior to the current study and/or who plan to participate the other clinical tests. 8\)Subjects who donated over 200mL blood and/or blood components within the last one month to the current study. 9\)Subjects who donated over 400mL blood and/or blood components within the last three month to the current study. 10\)Subjects who will be collected over 1200mL blood and/or blood components,when the sampling amounts within the last twelve month are adding to the planned sampling amounts of this study. 11\)Others who have been determined ineligible by principal investigator or sub\-investigator.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A study examining the relationship between blood flow waveform indices and lifestyle-related disease indicesHealthy adultsJPRN-UMIN000045013Kao Corporation200
Recruiting
Not Applicable
Clinical study to evaluate the efficacy of blood purification therapy on cholesterol crystal embolismcholesterol crystal embolismJPRN-UMIN000009306Incorporated administrative agency, Japan Community Health care Organization, Sendai Hospital35
Active, not recruiting
Not Applicable
Evaluation of the pharmacodynamic effect of the combination of Sildenafil and Riociguat on blood pressure and other safety parametersPulmonary arterial hypertensionMedDRA version: 14.1Level: PTClassification code 10064911Term: Pulmonary arterial hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2010-018863-40-DEBayer HealthCare AG18
Active, not recruiting
Not Applicable
An interaction study to evaluate changes in blood pressure following 1, 1.5, 2, and 2.5 mg riociguat tid (dose titration) compared to placebo treatment on the background of stable sildenafil pretreatment in subjects with symptomatic pulmonary arterial hypertension - PATENT PLUSPulmonary arterial hypertension.MedDRA version: 9.1Level: LLTClassification code 10064911EUCTR2010-018863-40-ITBayer Health Care AG36
Active, not recruiting
Not Applicable
Evaluation of the pharmacodynamic effect of the combination of Sildenafil and Riociguat on blood pressure and other safety parametersPulmonary arterial hypertensionMedDRA version: 14.1Level: PTClassification code 10064911Term: Pulmonary arterial hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2010-018863-40-CZBayer HealthCare AG36